PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |chronic kidney disease |
| Sentences | 122 |
| PubMedID- 21625102 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 23046408 | Updating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl-coa desaturase affair. |
| PubMedID- 21629196 | The increased risk of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd) has been well documented. |
| PubMedID- 21523678 | Diabetes, hypertension (hypertrophy and left ventricular failure), impaired fibrinolysis and coagulation processes, as well as the rapid development of atherosclerosis (partly associated with chronic inflammation) are responsible for higher prevalence of cardiovascular diseases in patients with chronic kidney disease. |
| PubMedID- 24632542 | Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 20576822 | Background and objectives: cardiovascular disease in chronic kidney disease (ckd) is explained in part by traditional cardiovascular risk factors; by uremia-specific factors; and by abnormalities of mineral metabolism, factors involved in its regulation, and in the vascular calcification process. |
| PubMedID- 22383696 | Cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 21076895 | Cardiovascular disease in chronic kidney disease: data from the kidney early evaluation program (keep). |
| PubMedID- 23470818 | Purpose of review: this review will examine advances in our understanding of the association between high-density lipoprotein (hdl) function and cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 22244796 | Background: accelerated vascular calcification contributes to cardiovascular disease burden in patients with chronic kidney disease (ckd). |
| PubMedID- 21387687 | [interventional revascularization for cardiovascular disease in patients with chronic kidney disease]. |
| PubMedID- 21983848 | Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease. |
| PubMedID- 25530222 | The use of vitamin d receptor activators (vdras) is an independent predictor of a lower risk of death from cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 23389416 | Elevated fibroblast growth factor 23 (fgf23) is associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23474010 | Background: chronic kidney disease is associated with cardiovascular disease. |
| PubMedID- 22923917 | Background: dyslipidemia has been established as a well-known traditional risk factor for cardiovascular disease in chronic kidney disease patients. |
| PubMedID- 25923753 | Introduction: metabolic syndrome (ms) has a high prevalence in hemodialysis' patients and is a risk factor for cardiovascular disease, the leading cause of mortality in chronic kidney disease (ckd). |
| PubMedID- 22660924 | Approach to cardiovascular disease prevention in patients with chronic kidney disease. |
| PubMedID- 21111939 | Background: endothelial dysfunction (ed) is closely linked to cardiovascular disease and outcome in patients with chronic kidney disease (ckd). |
| PubMedID- 25924679 | Background: reliable estimates of the impacts of chronic kidney disease (ckd) stage, with and without cardiovascular disease, on hospital costs are needed to inform health policy. |
| PubMedID- 22160646 | Purpose: advanced glycation end products (age), biomarkers of metabolic stress, are frequently encountered in chronic kidney disease (ckd) patients with cardiovascular disease. |
| PubMedID- 22822101 | Aims: increased serum phosphorus levels are associated with cardiovascular disease in patients with chronic kidney disease (ckd) and in the general population. |